Ruegg Curtis
Insider CIK 1597578 · RVNC EVP, Technical Operations
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2016-06-13 | 2016-06-15 | 1,000 | — | $0 | 48,836 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2016-06-13 | 2016-06-15 | 1,000 | $18.25 | $18.3K | 23,944 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2016-06-13 | 2016-06-15 | 1,000 | $8.70 | $8.7K | 24,944 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2016-05-19 | 2016-05-23 | 1,320 | $17.11 | $22.6K | 23,944 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2016-05-09 | 2016-05-11 | 1,000 | — | $0 | 49,836 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2016-05-09 | 2016-05-11 | 1,000 | $16.18 | $16.2K | 25,264 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2016-05-09 | 2016-05-11 | 1,000 | $8.70 | $8.7K | 26,264 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2016-04-11 | 2016-04-13 | 1,000 | — | $0 | 50,836 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2016-04-11 | 2016-04-13 | 1,000 | $19.11 | $19.1K | 25,264 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2016-04-11 | 2016-04-13 | 1,000 | $8.70 | $8.7K | 26,264 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2016-03-07 | 2016-03-09 | 1,000 | — | $0 | 51,836 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2016-03-07 | 2016-03-09 | 1,000 | $8.70 | $8.7K | 26,264 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2016-03-07 | 2016-03-09 | 1,000 | $20.43 | $20.4K | 25,264 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2016-02-09 | 2016-02-11 | 50,000 | — | $0 | 50,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2016-02-09 | 2016-02-11 | 8,000 | — | $0 | 25,264 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2016-02-08 | 2016-02-10 | 1,000 | — | $0 | 52,836 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2016-02-08 | 2016-02-10 | 1,000 | $18.14 | $18.1K | 17,264 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2016-02-08 | 2016-02-10 | 1,000 | $8.70 | $8.7K | 18,264 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2016-01-28 | 2016-02-01 | 763 | $20.30 | $15.5K | 17,264 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2016-01-06 | 2016-01-08 | 2,000 | — | $0 | 53,836 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2016-01-06 | 2016-01-08 | 2,000 | $8.70 | $17.4K | 20,027 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2016-01-06 | 2016-01-08 | 2,000 | $33.06 | $66.1K | 18,027 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2015-08-17 | 2015-08-19 | 3,000 | — | $0 | 55,836 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2015-08-17 | 2015-08-19 | 100 | $31.35 | $3.1K | 18,027 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2015-08-17 | 2015-08-19 | 400 | $30.18 | $12.1K | 18,127 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2015-08-17 | 2015-08-19 | 500 | $30.43 | $15.2K | 18,527 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2015-08-17 | 2015-08-19 | 500 | $30.60 | $15.3K | 19,027 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2015-08-17 | 2015-08-19 | 500 | $30.27 | $15.1K | 19,527 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2015-08-17 | 2015-08-19 | 1,000 | $30.13 | $30.1K | 20,027 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2015-08-17 | 2015-08-19 | 3,000 | $8.70 | $26.1K | 21,027 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2015-07-17 | 2015-07-21 | 1,164 | — | $0 | 58,836 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2015-07-17 | 2015-07-21 | 1,836 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2015-07-17 | 2015-07-21 | 3,000 | $31.03 | $93.1K | 18,027 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2015-07-17 | 2015-07-21 | 1,836 | $6.60 | $12.1K | 19,863 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2015-07-17 | 2015-07-21 | 1,164 | $8.70 | $10.1K | 21,027 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2015-06-17 | 2015-06-19 | 3,000 | — | $0 | 1,836 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2015-06-17 | 2015-06-19 | 3,000 | $33.53 | $100.6K | 18,027 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2015-06-17 | 2015-06-19 | 3,000 | $6.60 | $19.8K | 21,027 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2015-06-03 | 2015-06-05 | 500 | — | $0 | 4,836 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2015-06-03 | 2015-06-05 | 500 | $30.00 | $15.0K | 18,027 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2015-06-03 | 2015-06-05 | 500 | $6.60 | $3.3K | 18,527 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2015-05-19 | 2015-05-21 | 1,310 | $25.94 | $34.0K | 18,027 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2015-05-18 | 2015-05-19 | 2,500 | — | $0 | 5,336 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2015-05-18 | 2015-05-19 | 1,000 | $26.72 | $26.7K | 19,337 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2015-05-18 | 2015-05-19 | 500 | $26.68 | $13.3K | 20,337 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2015-05-18 | 2015-05-19 | 500 | $26.68 | $13.3K | 20,837 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2015-05-18 | 2015-05-19 | 500 | $26.70 | $13.3K | 21,337 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2015-05-18 | 2015-05-19 | 2,500 | $6.60 | $16.5K | 21,837 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2015-05-15 | 2015-05-19 | 500 | — | $0 | 7,836 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2015-05-15 | 2015-05-19 | 500 | $6.60 | $3.3K | 19,837 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2015-05-15 | 2015-05-19 | 500 | $25.00 | $12.5K | 19,337 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2015-04-17 | 2015-04-21 | 1,003 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2015-04-17 | 2015-04-21 | 997 | — | $0 | 8,336 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2015-04-17 | 2015-04-21 | 1,003 | $6.60 | $6.6K | 20,340 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2015-04-17 | 2015-04-21 | 1,000 | $22.23 | $22.2K | 19,340 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2015-04-17 | 2015-04-21 | 997 | $6.60 | $6.6K | 20,337 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2015-04-17 | 2015-04-21 | 1,000 | $22.24 | $22.2K | 19,337 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2015-03-19 | 2015-03-23 | 500 | — | $0 | 1,003 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2015-03-19 | 2015-03-23 | 500 | $6.60 | $3.3K | 19,837 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2015-03-19 | 2015-03-23 | 500 | $20.00 | $10.0K | 19,337 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2015-03-17 | 2015-03-19 | 1,500 | — | $0 | 1,503 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2015-03-17 | 2015-03-19 | 1,500 | $18.61 | $27.9K | 19,337 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2015-03-17 | 2015-03-19 | 1,500 | $6.60 | $9.9K | 20,837 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2015-03-09 | 2015-03-11 | 500 | — | $0 | 3,003 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2015-03-09 | 2015-03-11 | 500 | $6.60 | $3.3K | 19,837 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2015-03-09 | 2015-03-11 | 500 | $18.00 | $9.0K | 19,337 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2015-02-17 | 2015-02-18 | 170 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2015-02-17 | 2015-02-18 | 830 | — | $0 | 3,503 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2015-02-17 | 2015-02-18 | 830 | $16.80 | $13.9K | 19,337 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2015-02-17 | 2015-02-18 | 170 | $2.55 | $433 | 19,507 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2015-02-17 | 2015-02-18 | 170 | $16.80 | $2.9K | 20,167 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2015-02-17 | 2015-02-18 | 830 | $6.60 | $5.5K | 20,337 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2015-01-28 | 2015-01-30 | 29,644 | — | $0 | 29,644 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2015-01-28 | 2015-01-30 | 5,231 | — | $0 | 19,337 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2015-01-20 | 2015-01-22 | 1,000 | — | $0 | 170 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2015-01-20 | 2015-01-22 | 1,000 | $17.25 | $17.3K | 14,106 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2015-01-20 | 2015-01-22 | 1,000 | $2.55 | $2.5K | 15,106 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2015-01-09 | 2015-01-13 | 4 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2015-01-09 | 2015-01-13 | 496 | — | $0 | 1,170 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2015-01-09 | 2015-01-13 | 4 | $2.55 | $10 | 14,110 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2015-01-09 | 2015-01-13 | 496 | $2.55 | $1.3K | 14,606 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2015-01-09 | 2015-01-13 | 500 | $18.00 | $9.0K | 14,106 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2014-12-17 | 2014-12-19 | 1,000 | — | $0 | 4 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2014-12-17 | 2014-12-19 | 1,000 | $16.45 | $16.4K | 14,106 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2014-12-17 | 2014-12-19 | 1,000 | $2.55 | $2.5K | 15,106 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2014-12-09 | 2014-12-11 | 500 | — | $0 | 1,004 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2014-12-09 | 2014-12-11 | 500 | $18.00 | $9.0K | 14,106 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2014-12-09 | 2014-12-11 | 500 | $2.55 | $1.3K | 14,606 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2014-11-18 | 2014-11-20 | 1,000 | — | $0 | 1,504 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2014-11-18 | 2014-11-20 | 1,000 | $16.00 | $16.0K | 14,106 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2014-11-18 | 2014-11-20 | 1,000 | $2.55 | $2.5K | 15,106 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2014-10-28 | 2014-10-30 | 500 | — | $0 | 2,504 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2014-10-28 | 2014-10-30 | 500 | $2.55 | $1.3K | 13,768 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2014-10-28 | 2014-10-30 | 500 | $20.00 | $10.0K | 13,268 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2014-10-17 | 2014-10-21 | 1,500 | — | $0 | 3,004 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2014-10-17 | 2014-10-21 | 1,000 | $18.59 | $18.6K | 13,768 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2014-10-17 | 2014-10-21 | 500 | $18.50 | $9.3K | 13,268 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2014-10-17 | 2014-10-21 | 1,500 | $2.55 | $3.8K | 14,768 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2014-09-17 | 2014-09-19 | 1,162 | — | $0 | 4,504 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2014-09-17 | 2014-09-19 | 838 | $20.57 | $17.2K | 13,268 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2014-09-17 | 2014-09-19 | 500 | $20.51 | $10.3K | 14,606 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2014-09-17 | 2014-09-19 | 500 | $20.56 | $10.3K | 14,106 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2014-09-17 | 2014-09-19 | 162 | $20.50 | $3.3K | 15,106 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2014-09-17 | 2014-09-19 | 1,162 | $2.55 | $3.0K | 15,268 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2014-05-19 | 2014-05-21 | 31,500 | — | $0 | 31,500 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2014-05-19 | 2014-05-21 | 10,500 | $32.22 | $338.3K | 14,106 | SEC↗ |